Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare Sun

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 2018
Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic LeukemiaGeorg Aue, Clare Sun, Delong Liu, et al.
Diagnostic Microbiology and Infectious Disease|January 26, 2019
Protracted course of disseminated adenovirus disease with necrotizing granulomas in the liverAndrea M Lerner, John E Bennett, Stefania Pittaluga, et al.
Blood|December 1, 2020
Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccinesChristopher Pleyer, Mir A Ali, Jeffrey I Cohen, et al.
Blood|May 11, 2018
A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib eraHannah R Robinson, Junpeng Qi, Erika M Cook, et al.
Blood Advances|February 14, 2022
BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLLChristopher Pleyer, Kerry J Laing, Mir A Ali, et al.
American Journal of Hematology|August 19, 2020
A phase II study of ibrutinib and short-course fludarabine in previously untreated patients with chronic lymphocytic leukemiaChristopher Pleyer, Xin Tian, Shakuntala Rampertaap, et al.
Haematologica|September 30, 2021
Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patientsJennifer R Brown, John C Byrd, Paolo Ghia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2023
CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor TherapyAnfal Alsadhan, Jonathan Chen, Erika M Gaglione, et al.
Blood Advances|March 31, 2022
The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemiaClare Sun, Yun-Ching Chen, Aina Martinez Zurita, et al.
Briefings in Bioinformatics|October 17, 2025
Numbat-multiome: inferring copy number variations by combining RNA and chromatin accessibility information from single-cell dataRuitong Li, Jean-Baptiste Alberge, Tina Keshavarzian, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 2018
Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic LeukemiaGeorg Aue, Clare Sun, Delong Liu, et al.
Diagnostic Microbiology and Infectious Disease|January 26, 2019
Protracted course of disseminated adenovirus disease with necrotizing granulomas in the liverAndrea M Lerner, John E Bennett, Stefania Pittaluga, et al.
Blood|December 1, 2020
Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccinesChristopher Pleyer, Mir A Ali, Jeffrey I Cohen, et al.
Blood|May 11, 2018
A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib eraHannah R Robinson, Junpeng Qi, Erika M Cook, et al.
Blood Advances|February 14, 2022
BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLLChristopher Pleyer, Kerry J Laing, Mir A Ali, et al.
American Journal of Hematology|August 19, 2020
A phase II study of ibrutinib and short-course fludarabine in previously untreated patients with chronic lymphocytic leukemiaChristopher Pleyer, Xin Tian, Shakuntala Rampertaap, et al.
Haematologica|September 30, 2021
Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patientsJennifer R Brown, John C Byrd, Paolo Ghia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2023
CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor TherapyAnfal Alsadhan, Jonathan Chen, Erika M Gaglione, et al.
Blood Advances|March 31, 2022
The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemiaClare Sun, Yun-Ching Chen, Aina Martinez Zurita, et al.
Briefings in Bioinformatics|October 17, 2025
Numbat-multiome: inferring copy number variations by combining RNA and chromatin accessibility information from single-cell dataRuitong Li, Jean-Baptiste Alberge, Tina Keshavarzian, et al.
Pageof 6